Ghent University Academic Bibliography

Your filters: cql: author="Schulte, Johannes H" or (type any "bookEditor issueEditor" and editor="Schulte, Johannes H")

Add to list
- Journal Article
- A1
- open access
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets

Bieke Decaesteker (UGent) , Geertrui Denecker (UGent) , Christophe Van Neste (UGent) , Emmy M Dolman, Wouter Van Loocke (UGent) , Moritz Gartlgruber, Carolina de Carvalho Nunes, Fanny De Vloed (UGent) , Pauline Depuydt, Karen Verboom, et al.

(2018) NATURE COMMUNICATIONS. 9.
Add to list
A mechanistic classification of clinical phenotypes in neuroblastoma.

Sandra Ackermann, Maria Cartolano, Barbara Hero, Anne Welte, Yvonne Kahlert, Andrea Roderwieser, Christoph Bartenhagen, Esther Walter, Judith Gecht, Laura Kerschke, et al.

(2018) SCIENCE. 362(6419). p.1165-1170
Add to list
- Journal Article
- A1
- open access
Targeting tachykinin receptors in neuroblastoma

Anton G Henssen, Andrea Odersky, Annabell Szymansky, Marleen Seiler, Kristina Althoff, Anneleen Beckers (UGent) , Franki Speleman (UGent) , Simon Schäfers, Katleen De Preter (UGent) , Kathy Astrahanseff, et al.

(2017) ONCOTARGET. 8(1). p.430-443
Add to list
- Journal Article
- A1
- open access
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells

Kathrin Fielitz, Kristina Althoff, Katleen De Preter (UGent) , Julie Nonnekens, Jasmin Ohli, Sandra Elges, Wolfgang Hartmann, Günter Klöppel, Thomas Knösel, Marc Schulte, et al.

(2016) ONCOTARGET. 7(45). p.74415-74426
Add to list
Targeting MYCN-driven transcription by BET-bromodomain inhibition

Anton G Henssen, Kristina Althoff, Andrea Odersky, Anneleen Beckers (UGent) , Richard Koche, Franki Speleman (UGent) , Simon Schaefer, Emma Bell, Maike Nortmeyer, Frank Westermann, et al.

(2016) CLINICAL CANCER RESEARCH. 22(10). p.2470-2481
Add to list
- Conference Paper
- C3
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2016) OncoPoint, 4th Research seminar, Abstracts.
Add to list
- Journal Article
- A1
- open access
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2016) ONCOTARGET. 7(2). p.1960-1972
Add to list
- Journal Article
- A1
- open access
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

Johannes Fabian, Desirée Opitz, Kristina Althoff, Marco Lodrini, Barbara Hero, Ruth Volland, Anneleen Beckers (UGent) , Katleen De Preter (UGent) , Anneleen Decock (UGent) , Nitin Patil, et al.

(2016) ONCOTARGET. 7(41). p.66344-66359
Add to list
- Journal Article
- A1
- open access
Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors

Melanie Schwermer, Sangkyun Lee, Johannes Koester, Tom Van Maerken (UGent) , Harald Stephan, Angelika Eggert, Katharina Morik, Johannes H Schulte and Alexander Schramm

(2015) ONCOTARGET. 6(17). p.15425-15435
Add to list
- Journal Article
- A1
- open access
MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation

Anneleen Beckers (UGent) , Gert Van Peer (UGent) , Daniel R Carter, Kristina Althoff, Belamy B Cheung, Johannes H Schulte, Pieter Mestdagh (UGent) , Jo Vandesompele (UGent) , Glenn M Marshall, Katleen De Preter (UGent) , et al.

(2015) ONCOTARGET. 6(7). p.5204-5216

Academic Bibliography

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets

A mechanistic classification of clinical phenotypes in neuroblastoma.

Targeting tachykinin receptors in neuroblastoma

Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells

Targeting MYCN-driven transcription by BET-bromodomain inhibition

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors

MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation

Contents

Support

Contact